11:50 AM EST - Intellipharmaceutics International Inc. : reported the results of operations for the three months ended February 28, 2015. All dollar amounts referenced herein are in United States dollars. The Company recorded a net loss for the three months ended February 28, 2015 of $0.9 million or $0.04 per diluted common share, compared with a net income of $2.2 million or $0.09 per common share for the three months ended February 28, 2014. Intellipharmaceutics International Inc.
shares T.I are trading down $0.16 at $3.47.
